Literature DB >> 29038321

Testosterone use causing erythrocytosis.

Andrea Cervi1, Amaris K Balitsky2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29038321      PMCID： PMC5647167          DOI： 10.1503/cmaj.170683

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Reversal of polycythaemia induced by intramuscular androgen replacement using transdermal testosterone therapy.

Authors:  H Siddique; J C Smith; R J M Corrall
Journal:  Clin Endocrinol (Oxf)       Date:  2004-01       Impact factor: 3.478

Review 2.  Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline.

Authors:  Alvaro Morales; Richard A Bebb; Priya Manjoo; Peter Assimakopoulos; John Axler; Christine Collier; Stacy Elliott; Larry Goldenberg; Irv Gottesman; Ethan D Grober; Gordon H Guyatt; Daniel T Holmes; Jay C Lee
Journal:  CMAJ       Date:  2015-10-26       Impact factor: 8.262

Review 3.  The diagnosis and management of erythrocytosis.

Authors:  Clodagh Keohane; Mary Frances McMullin; Claire Harrison
Journal:  BMJ       Date:  2013-11-18

Review 4.  Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2010-06       Impact factor: 5.958

5.  Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.

Authors:  Eric Bachman; Thomas G Travison; Shehzad Basaria; Maithili N Davda; Wen Guo; Michelle Li; John Connor Westfall; Harold Bae; Victor Gordeuk; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-24       Impact factor: 6.053

6.  Hematocrit and risk of venous thromboembolism in a general population. The Tromso study.

Authors:  Sigrid K Braekkan; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen
Journal:  Haematologica       Date:  2009-10-14       Impact factor: 9.941

7.  Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.

Authors:  Andrea D Coviello; Beth Kaplan; Kishore M Lakshman; Tai Chen; Atam B Singh; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958

8.  Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up.

Authors:  D R Gagnon; T J Zhang; F N Brand; W B Kannel
Journal:  Am Heart J       Date:  1994-03       Impact factor: 4.749

Review 9.  Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.

Authors:  T Barbui; J Thiele; A M Vannucchi; A Tefferi
Journal:  Blood Cancer J       Date:  2015-08-14       Impact factor: 11.037
  9 in total
  3 in total

Review 1.  Investigation and management of erythrocytosis.

Authors:  Siraj Mithoowani; Marissa Laureano; Mark A Crowther; Christopher M Hillis
Journal:  CMAJ       Date:  2020-08-10       Impact factor: 8.262

2.  Longitudinal Changes in Hematologic Parameters Among Transgender People Receiving Hormone Therapy.

Authors:  Ana Antun; Qi Zhang; Shalender Bhasin; Andrew Bradlyn; W Dana Flanders; Darios Getahun; Timothy L Lash; Rebecca Nash; Douglas Roblin; Michael J Silverberg; Vin Tangpricha; Suma Vupputuri; Michael Goodman
Journal:  J Endocr Soc       Date:  2020-08-25

3.  Intermittent Hypoxia Exposure Helps to Restore the Reduced Hemoglobin Concentration During Intense Exercise Training in Trained Swimmers.

Authors:  Xiquan Weng; Jieru Lin; Yu Yuan; Baoxuan Lin; Weiwei Huang; Hiu Tung Tin; Jia Li; Xu Yan; Wentao Lin; Hao Chen
Journal:  Front Physiol       Date:  2021-11-29       Impact factor: 4.566
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.